LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Sleeboom-Faulkner, Margaret; Chang, Hung-Chieh (2016)
Publisher: Taylor & Francis
Languages: English
Types: Article
Subjects:
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [4] Martell K, Trounson E, Baum E. Stem cell therapies in clinical trials: workshop on best practices and the need for harmonization. Cell Stem Cell 7(4), 451-454 (2010).
    • [13] FDA. Accelerated Approval.
    • http://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm
    • [14] FDA. Breakthrough Therapies.
    • http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstothe FDCAct/FDASIA/ucm329491.htm
    • [15] FDA. Priority Review.
    • http://www.fda.gov/ForPatients/Approvals/Fast/ucm405405.htm
    • [42] Ministry of Science, Technology and Innovation of Argentina. Crece el debate sobre las terapias avanzadas en la Argentina. Press Release (2016).
    • http://www.mincyt.gob.ar/_post/descargar.php?idAdjuntoArchivo=47765
    • [43] Krmpotic C. Creer en la cura: Eficacia simbólica y control social en las prácticas del Dr. M., Scripta Ethnologica, 33, 97-116 (2011).
    • [50] Turner L, Knoepfler P. Selling stem cells in the USA: assessing the direct-toconsumer industry, Cell Stem Cell, doi: 10.1016/j.stem2016.06.007 (2016).
    • [51] Song P. Biotech Pilgrims and the Transnational Quest for Stem Cell Cures.
    • Medical Anthropology, 29(4), 37-41 (2010).
    • [52] Ogbogu U, Rachul C, Caulfield T. Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?, Regenerative Medicine, 8(3), 361- 369 (2013).
    • [53] Bianco P, Sipp D. Sell Help not Hope, Nature 510(7505), 336-337 (2014).
    • [54] Rosemann A. Multi-country stem cell trials: the need for an international support structure. Stem Cell Research 14(3), 396-400 (2015).
    • [55] Ravinetto RM, Talisuna A, Crop M, et al. Challenges of non-commercial multicentre North-South collaborative clinical trials. Tropical Medicine and International Health 18(2), 237-241 (2013).
    • [56] Hourd P, Chandra A, Medcalf N, Williams G. Regulatory challenges for the manufacture and scale-out of autologous cell therapies (2014).
    • http://www.ncbi.nlm.nih.gov/books/NBK201975/
    • [57] Minisman G, Bhanushali M, Conwit R, et al. Implementing clinical trials on an international platform: Challenges and perspectives. Journal of the Neurological Sciences 313(1), 1-6, (2012).
    • [58] Keirstead H. Translation of stem cell therapies. Spinal Cord Injury - what are the barriers to cure?. Bedford Center Workshop, Weston Massachusetts, November 9, 2012. http://www.spinalcordworkshop.org/portfolio-type/hans-keirstead-phdtranslation-of-stem-cell-based-therapies/ [60] Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials.
    • Regenerative Medicine 9(1), 27-39 (2014).
  • No related research data.
  • No similar publications.

Share - Bookmark

Funded by projects

  • EC | BIONETWORKING
  • RCUK | Bionetworking in Asia - In...

Cite this article